enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. 28 of the Best Menopause Products to Get You Through Hot Flashes

   www.aol.com/lifestyle/29-best-menopause-products...

   The North American Menopause Society states that the average age of the menopause begins at 52, but the age of natural menopause can vary widely from 40 to 58 years. Whenever you do go through ...

3. An experimental pill cut hot flashes and improved sleep for ...

   www.aol.com/experimental-pill-cut-hot-flashes...

   After 12 weeks, women taking elinzanetant were reporting having about 10 fewer hot flashes each day on average compared with an average change of about seven hot flashes each day in the placebo group.

4. Hot flashes: Here's what's causing them and ways to help ...

   www.aol.com/lifestyle/hot-flashes-heres-whats...

   "Many women have complaints of hot flashes for a long time, lasting between seven to nine years," Mason says. However, they tend to decline in severity after three or four years. Each hot flash ...

5. Hot flash - Wikipedia

   en.wikipedia.org/wiki/Hot_flash

   If hot flashes occur at other times in a young female's menstrual cycle, then it might be a symptom of a problem with the pituitary gland; seeing a doctor is highly recommended. In younger females who are surgically menopausal, hot flashes are generally more intense than in older females, and they may last until natural age at menopause. [3]

6. Night sweats - Wikipedia

   en.wikipedia.org/wiki/Night_sweats

   One of the most common causes of night sweats in women over 40 is the hormonal changes related to menopause and perimenopause. [3] This is a very common occurrence during the menopausal transition years. Over 80% of women experience hot flashes, which may include excessive sweating, during menopause. [4]

7. Fezolinetant - Wikipedia

   en.wikipedia.org/wiki/Fezolinetant

   Fezolinetant, sold under the brand name Veozah among others, is a medication used for the treatment of hot flashes (vasomotor symptoms) due to menopause. [3] [9] It is a small-molecule, orally active, selective neurokinin-3 (NK 3) receptor antagonist which is under development by for the treatment of sex hormone-related disorders.